0000899243-23-007726.txt : 20230309 0000899243-23-007726.hdr.sgml : 20230309 20230309160018 ACCESSION NUMBER: 0000899243-23-007726 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230220 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sprague John M CENTRAL INDEX KEY: 0001730056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 23719597 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-20 0 0001492674 T2 Biosystems, Inc. TTOO 0001730056 Sprague John M 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Common Stock 2023-02-20 4 M 0 4000 A 7047 D Common Stock 2023-02-22 4 S 0 1545 0.65 D 5502 D Common Stock 2023-02-24 4 M 0 2914 A 8416 D Common Stock 2023-02-28 4 S 0 1148 0.59 D 7268 D Restricted Stock Units 2023-02-20 4 M 0 4000 0.00 D Common Stock 4000 8000 D Restricted Stock Units 2023-02-24 4 M 0 2914 0.00 D Common Stock 2914 2914 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person adopted by the reporting person on June 15, 2018. On February 20, 2022 the reporting person was granted 12,000 RSU's that vest in three equal annual installments commencing on February 20, 2023 On February 24, 2021 the reporting person was granted 8,743 RSU's that vest in three equal annual installments commencing on February 24, 2022. /s/ John Sprague, Attorney-in-fact 2023-03-09